Risk to Your Cognition: Sepsis, Smoking Wreak Havoc Years Later
Two large, prospective studies published this week solidify claims that midlife habits and acute predicaments can take a serious toll on brain health years down the road...
6381 RESULTS
Sort By:
Two large, prospective studies published this week solidify claims that midlife habits and acute predicaments can take a serious toll on brain health years down the road...
How many Americans have amyotrophic lateral sclerosis?...
Small, soluble oligomers of amyloid-β (Aβ) are now widely believed to be the most toxic form of the peptide...
The much-awaited announcement that ADNI2 will go ahead was made 21 October 2010 by the National Institutes of Health...
Amidst all the promise of stem cell technology, there is also a heaping share of worry...
There is evidence that Aβ can go from the blood to the brain...
Could the field be one step closer to a new potential therapy for AD? Possibly, if the target is striatal-enriched tyrosine phosphatase (STEP)...
Mutated superoxide dismutase 1 contorts itself into strange and unnatural shapes, leading to amyotrophic lateral sclerosis...
A $40 million multicenter biomarker study for Parkinson disease progression is off and running, with enrollment underway at 10 of 18 sites in the U.S. and Europe. In design and operation, the Parkinson's Progression Markers Initiative (PPMI) follow
PPMI was launched in July with hopes of identifying a biomarker, or set of markers, that tracks the natural course of Parkinson disease...
One of the great challenges with developing treatments for neurodegenerative disorders stems from the capricious nature of disease progression...
Hard on the heels of a recent debate about the value of preventive measures for Alzheimer disease (AD) come some new data on physical activity...
Is apoptosis is a core process early in ALS, or merely the swan song of cells that have lost the ability to do anything other than make a graceful exit...
Gene therapy is an important research strategy and carries hope of becoming a viable treatment in neurodegenerative disease...
Two Faces of Evil: Cancer and Neurodegeneration Ipsen Colloquium on Alzheimer's Disease